FindTrial
Sign In

Exploration of CD47 as a therapeutic target for alcoholic liver disease

Study on the Treatment of Non-Alcoholic Fatty Liver Disease with CD47 Peptide

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111065
Enrollment
Unknown
Registered
2025-10-24
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NASH

Interventions

Control group and observation group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.A signed and dated informed consent form. 2. Commit to adhering to the research procedures and cooperate with the implementation of the entire research process.

Exclusion criteria

Exclusion criteria: 1.The patient voluntarily requested to withdraw.

Design outcomes

Primary

MeasureTime frame
Improvement of fatty liver;—

Countries

China

Contacts

Public ContactMin Li

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

liminmed@126.com+86 27 8572 6375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026